Date | Time | Source | Headline | Symbol | Company |
02/14/2017 | 7:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
09/09/2016 | 9:06AM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
09/06/2016 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
09/02/2016 | 3:30PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
09/01/2016 | 6:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
09/01/2016 | 6:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/31/2016 | 6:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/30/2016 | 2:56PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/30/2016 | 2:51PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/29/2016 | 4:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/29/2016 | 4:12PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/29/2016 | 1:17PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/29/2016 | 7:58AM | Business Wire | Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stoc... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/29/2016 | 6:17AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/24/2016 | 9:23AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/22/2016 | 5:51PM | PR Newswire (US) | Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600 | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/22/2016 | 6:10AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/18/2016 | 4:56PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
08/18/2016 | 4:39PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |